Medical Market Report

Global Transcriptomics Market By Type (Real Time-PCR (qPCR), Microarray, Sequencing), By Application (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Contract research Organizations (CROs)), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135680
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Transcriptomics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transcriptomics Market is segmented on the basis of Type, Application, and geography.
    The worldwide market for Global Transcriptomics Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Transcriptomics Market Scope:

    By type, the market is segmented into Real Time-PCR (qPCR), Microarray, and Sequencing. By Application, the market is divided into Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, and Contract research Organizations (CROs).
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include QIAGEN (Exiqon), Thermo Fisher Scientific, Illumina, Agilent Technologies, GE Healthcare Dharmacon, Bio-Rad Laboratories, F. Hoffmann-La Roche, Merck, Fluidigm Corporation, and Promega Corporation.

    Key Market Segments

    Type

    Real Time-PCR (qPCR)

    Microarray

    Sequencing

    Application

    Government Institutes & Academic Centers

    Pharmaceutical & Biotechnology Companies

    Contract research Organizations (CROs)

    Key Market Players included in the report:

    QIAGEN (Exiqon)

    Thermo Fisher Scientific

    Illumina

    Agilent Technologies

    GE Healthcare Dharmacon

    Bio-Rad Laboratories

    F. Hoffmann-La Roche

    Merck

    Fluidigm Corporation

    Promega Corporation

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Transcriptomics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Transcriptomics Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Transcriptomics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transcriptomics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Transcriptomics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Transcriptomics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Transcriptomics Market sub-markets, depending on key regions (various vital states).
    To analyze Global Transcriptomics Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Transcriptomics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Transcriptomics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Transcriptomics Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Transcriptomics Market Overview
    

    3.1. Global Transcriptomics Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Manufacturer Intensity Map4. Global Transcriptomics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Transcriptomics Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Real Time-PCR (qPCR)
    

      4.4. Microarray
    

      4.5. Sequencing5. Global Transcriptomics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Transcriptomics Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Government Institutes & Academic Centers
    

      5.4. Pharmaceutical & Biotechnology Companies
    

      5.5. Contract research Organizations (CROs)6. Global Transcriptomics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Global Transcriptomics Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Global Transcriptomics Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Global Transcriptomics Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia
    

      6.4. Latin America
    

        6.4.1. Latin America Global Transcriptomics Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Global Transcriptomics Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Transcriptomics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. QIAGEN (Exiqon)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3. 3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Thermo Fisher Scientific
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4. 4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Illumina
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5. 5. Key Strategies and Developments  7.6. Agilent Technologies
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. GE Healthcare Dharmacon
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Bio-Rad Laboratories
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. F. Hoffmann-La Roche
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7. 10.Merck
    

        7. 10.1. Company Overview
    
    7. 10.2. Financial Highlights
    
    7. 10.3. Product Portfolio
    
    7. 10.4. SWOT Analysis
    
    7. 10.5. Key Strategies and Developments  7. 11. Fluidigm Corporation
    

        7. 11.1. Company Overview
    
    7. 11.2. Financial Highlights
    
    7. 11.3. Product Portfolio
    
    7. 11.4. SWOT Analysis
    
    7. 11.5. Key Strategies and Developments  7. 12. Promega Corporation
    

        7. 12.1. Company Overview
    
    7. 12.2. Financial Highlights
    
    7. 12.3. Product Portfolio
    
    7. 12.4. SWOT Analysis
    
    7. 12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10.Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.